Immunoproteomic services refer to the use of proteomics techniques to study the immune system and its functions. In the context of aging, immunoproteomic services can be used to investigate how the immune system changes with age and how these changes may contribute to age-related diseases. CD BioSciences, a leading company specializing in biological research, offers cutting-edge immunoproteomic services to advance aging research.
Overview of Our Immunoproteomic Services
By employing a multidimensional approach, we aim to unravel the intricate molecular changes occurring within the aging immune system. Our services encompass protein profiling and quantification, cytokine and chemokine profiling, analysis of protein modifications, protein-protein interaction analysis, and evaluation of anti-aging therapies.
Protein profiling and quantification during the aging process
We perform the comprehensive profiling and quantification of immune-related proteins in samples from aging individuals, using techniques such as mass spectrometry-based proteomics or antibody-based protein assays. By comparing protein expression levels between different age groups or disease conditions, our clients can identify age-related changes in protein abundance.
Analysis of protein modifications in aging
We provide immunoproteomic services to investigate post-translational modifications (PTMs) of proteins, such as phosphorylation, glycosylation, or acetylation, in immune-related proteins in aging. This analysis can uncover age-related changes in PTMs and their impact on immune cell signaling and function.
Cytokine and chemokine profiling
Our immunoproteomic services can offer cytokine and chemokine profiling to assess the levels of immune signaling molecules in aging individuals. This analysis can help identify age-related changes in the inflammatory profile and alterations in immune cell communication.
Our Workflow of Immunoproteomic Services
- Sample collection and immune cell isolation
We begin with the collection of biological samples, such as blood, serum, or tissue specimens, from individuals across different age groups. Once the samples are collected, we isolate immune cells of interest.
- Immunoproteomic analysis
Our team of experts utilizes a variety of techniques for immunoproteomic analysis, including mass spectrometry-based proteomics, antibody-based protein assays, and specialized assays for post-translational modifications. These techniques enable us to comprehensively profile immune-related proteins, quantify protein expression levels, identify age-related changes in protein abundance, and investigate protein modifications associated with aging.
- Data analysis and interpretation
We employ advanced bioinformatics tools and statistical analyses to process and interpret the immunoproteomic data.
Techniques Tools for Immunoproteomic Services
CD BioSciences utilizes a wide array of techniques and tools to ensure accurate and comprehensive immunoproteomic analysis in aging research.
Mass spectrometry (MS)
In aging research, we commonly utilize high-resolution mass spectrometry platforms, such as liquid chromatography-tandem mass spectrometry (LC-MS/MS), to analyze the protein content of biological samples, thus enabling the comprehensive profiling of immunoproteins associated with aging.
Antibody-based protein assays
We employ a wide range of antibodies validated for immunoproteomic analysis, enabling accurate measurement of protein expression levels and identification of potential biomarkers associated with aging.
Protein microarray technology
In aging research, we employ protein microarrays to assess age-related changes in protein expression and post-translational modifications across the immune proteome.
CD BioSciences offers a comprehensive range of immunoproteomic services tailored specifically for aging research, encompassing protein profiling and quantification, cytokine and chemokine profiling, and analysis of protein modifications. If you are interested in our services, please feel free to contact us or make an online inquiry.
All of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
